Mentice has announced a co-marketing agreement with Siemens Healthineers that enables access to the Ankyras clinical decision-support software with Siemens Healthineers’ Artis Icono angiography systems, and includes joint promotional activities through the Artis Icono product platform.
The partnership aims to expand clinician access to advanced, patient-specific aneurysm treatment planning by combining state-of-the-art angiography systems from Siemens Healthineers with Ankyras—Mentice’s predictive modelling software, which is commercially available in the EU, USA, and Brazil.
A recent press release from Mentice notes that, through this agreement, clinicians using Artis Icono systems will be able to seamlessly access Ankyras as part of their clinical workflow. Imaging data acquired on Artis Icono can be transferred directly to Ankyras, allowing physicians to virtually plan and simulate neurointerventional flow-diverter treatments using patient-specific anatomy.
Ankyras supports interventional neuroradiologists in selecting a flow diverter by predicting device behaviour—including foreshortening and landing zones—prior to the procedure. This enables more informed decision-making and supports procedural confidence without additional radiation exposure or patient risk, Mentice also claims.
By enabling the use of Ankyras in the angio-suite environment, the recently announced collaboration brings advanced treatment planning closer to routine clinical practice, helping clinicians prepare for complex intracranial aneurysm cases with greater precision and efficiency.
The co-marketing agreement includes a broad set of collaborative activities designed to increase awareness and adoption of Ankyras in combination with Artis Icono systems. The collaboration spans co-branded digital presence, inclusion of Ankyras in Siemens Healthineers’ sales and customer engagements, and coordinated promotional activities across events, education, and digital channels.
